![Jude Onyia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jude Onyia
Hoofd Techniek/Wetenschap/O&O bij
NEUROCRINE BIOSCIENCES, INC.
Vermogen: 3 M $ op 31-08-2026
Profiel
Currently, Jude Onyia is Director at Voyager Therapeutics, Inc. since 2023 and Chief Scientific Officer at Neurocrine Biosciences, Inc. since 2021.
Formerly, Dr. Onyia was Vice President-Biotechnology Discovery Research at Eli Lilly & Co. from 2014 to 2021 and Chief Scientific Officer at Capsida Biotherapeutics, Inc. in 2021.
Education includes a doctorate from State University of New York at Downstate Medical Center, an undergraduate degree from Suny College of Environmental Science & Forestry, and a doctorate from SUNY Upstate Medical University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-09-2026 | 22.647 ( 0,02% ) | 3 M $ | 31-08-2026 | |
| 09-06-2026 | 2.910 ( 0% ) | 10 040 $ | 31-08-2026 |
Actieve functies van Jude Onyia
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 30-11-2021 |
| VOYAGER THERAPEUTICS, INC. | Directeur/Bestuurslid | 21-02-2023 |
Eerdere bekende functies van Jude Onyia
| Bedrijven | Functie | Einde |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-06-2021 |
Opleiding van Jude Onyia
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
93
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
SUNY College of Environmental Science
 SUNY College of Environmental Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
